Registration on CoWIN must for those between 18-45 yrs to get vaccine shot

Those above 45 years can still avail the facility of on-site registration to get vaccinated

Covishield
Covishield (Photo: PTI)
Press Trust of India New Delhi
3 min read Last Updated : Apr 25 2021 | 3:09 PM IST

Don't want to miss the best from Business Standard?

Getting registered on the CoWIN web portal and taking an appointment to get a COVID-19 vaccine jab would be mandatory for those aged between 18 and 45 years as walk-ins will not be allowed initially, official sources said on Sunday.

Those above 45 years can still avail the facility of on-site registration to get vaccinated, they said.

As India witnesses a sudden surge in coronavirus cases, it has decided to allow everyone above18 years of age to get vaccinated from May 1.

"An increased demand is expected once the vaccination is opened for all. For the purpose of crowd control, registering on CoWIN portal and making an appointment to get a vaccine will be mandatory for those aged between 18 and 45 years. Walks-in will not be allowed in the beginning so that there is no chaos," an official said.

Registration for vaccination for all those aged above 18 will begin on the CoWIN platform and Aarogya Setu App from April28. The inoculation process and documents to be provided to get the jab remains the same.

From May 1, the present system of private COVID-19 vaccination centres receiving doses from the government and charging up to Rs 250 per dose from people will cease to exist and private hospitals will procure directly from vaccine manufacturers.

According to the Liberalised Pricing and Accelerated National COVID-19 Vaccination Strategy,COVID-19 vaccination will continue to be free for eligible population groups comprising healthcare workers, frontline workers and population above 45 years of age in government vaccination centres that receive doses from the Centre.

Vaccine manufacturers would make an advance declaration of the price for 50 per cent supply that would be available to state governments in the open market before May 1. Based on this price, states, private hospitals, industrial establishments may procure vaccine doses from manufacturers.

Private hospitals would have to procure their supplies of COVID-19 vaccine exclusively from the 50 per cent supply earmarked, other than the Government of India channel.

"While the Centre has liberalised the vaccination policy, it does not mean that vaccines will be sold in pharmacists or chemist shops in the open market," Health Secretary Rajesh Bhushan had clarified on Wednesday.

The price charged for vaccination by private hospitals would be monitored, he said, adding "The present dispensation where private COVID vaccination centres receive doses from the government and can charge up to Rs 250 per dose will cease to exist."

Vaccine manufacturers would supply 50 per cent of their monthly Central Drugs Laboratory (CDL) released doses to the Centre and and would be free to supply the rest to state governments.

All immunisations will be part of the National Vaccination Programme, will be captured on CoWIN platform along with stocks and price per vaccination applicable in all vaccination centres, will comply with adverse event following immunization management and reporting, and all other prescribed norms.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusCoronavirus VaccineCoronavirus Tests

First Published: Apr 25 2021 | 3:09 PM IST

Next Story